Novartis announces agreement to acquire Genoptix, Inc. in all cash offer
24 January 2011 | By Novartis
Novartis announced today that it has entered into a definitive agreement for the acquisition of Genoptix, Inc...
List view / Grid view
News
Novartis gains approval for Gilenya® as a first-line disease modifying oral therapy for multiple sclerosis in Switzerland and Australia
24 January 2011 | By Novartis
Swissmedic and TGA have granted approval for Gilenya® (fingolimod)...
AstraZeneca Replies To The US FDA Complete Response Letter For BRILINTA (Ticagrelor Tablets)
21 January 2011 | By AstraZeneca
AstraZeneca announced it has replied to the US FDA Complete Response Letter received for the ticagrelor (BRILINTA) New Drug Application...
Cognizant Selected by Lilly to Deliver Commercial Operations Solutions to Enhance Sales and Marketing Effectiveness, Business Performance
20 January 2011 | By Brands2Life
Cognizant, announced that it has been selected by Eli Lilly and Company...
Merck KGaA and Lead Discovery Center Enter Collaboration for the Discovery of Anti-Cancer Compounds
20 January 2011 | By Merck Serono
Merck Serono, announced today that Merck KGaA has signed a cooperation agreement with the Lead Discovery Center GmbH (LDC)...
Statement from Lilly and Avid on FDA Advisory Committee Recommendation for Amyvid(TM) (Florbetapir) NDA
20 January 2011 | By Eli Lilly and Company
The U.S. FDA Peripheral and Central Nervous System Drugs Advisory Committee decided today that it could not recommend approval of Amyvid™ (florbetapir) at this time...
Erbitux Long-Term Survival Benefit for mCRC Patients Confirmed With FOLFOX
19 January 2011 | By Merck KGaA
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today highlighted a further analysis of the large randomized Phase II OPUSa study...
Public/private partnership improves UK’s clinical research competitiveness
18 January 2011 | By National Institute for Health Research
A new report shows collaboration between the life sciences industry, the NHS and the National Institute for Health Research (NIHR) Clinical Research Network...
GlaxoSmithKline announces Q4 2010 legal charge
18 January 2011 | By GlaxoSmithKline (GSK)
GSK expects to record a legal charge for the fourth quarter of 2010 of £2.2 billion ($3.4 billion)...
Changes to the Roche Corporate Executive Committee
17 January 2011 | By Roche
Erich Hunziker, Chief Financial Officer, Chief Information Officer and Deputy Head of the Corporate Executive Committee has decided to retire from Roche at the end of March 2011...
Domain Therapeutics and Merck Serono announce an agreement to develop drugs for Parkinson’s disease
17 January 2011 | By Andrew Lloyd & Associates
Agreement covers metabotropic glutamate receptor 4 (mGluR4) Positive Allosteric Modulator (PAM) drugs targeting Parkinson's disease...
Molecular Profiles expands offering with new manufacturing capabilities
17 January 2011 | By The Scott Partnership
Expansion enables them to handle larger projects from preformulation through to Phase IIa...
Dr Eric Gluck to present benefits of Thermo Scientific B.R.A.H.M.S procalcitonin (PCT) assay
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that Dr Eric Gluck will host a scientific presentation highlighting the benefits of the Thermo Scientific B.R.A.H.M.S procalcitonin (PCT) assay at the Society of Critical Care Medicine (SCCM) 40th Critical Care Conference 2011.
Seeing is believing – 3D scanning with Tecan’s Infinite® M1000
13 January 2011 | By KDM Communications
Scientists at the Center for CIPSM, have taken advantage of the 3D scanning capabilities of the premium Quad4 Monochromators™-based Infinite M1000 microplate reader...
U.S. Food and Drug Administration (FDA) votes to recommend non-approval of liprotamase
12 January 2011 | By Eli Lilly and Company
Eli Lilly announces that the FDA Gastrointestinal Drugs Advisory Committee has recommended that additional studies be conducted...
